|
Non-executive Chairman appointed 12 August 2008. Formerly President and Chief Executive Officer of molecular diagnostics company, Digene Corporation, and a member of its board of directors prior to its sale to Qiagen N.V. in 2007. Prior to joining Digene, Mr. Faulkner spent eight years at Invitrogen Corp., a life sciences company, serving in several senior level capacities. Previously, Mr. Faulkner served for 15 years in a variety of roles at Abbott Laboratories Inc., a diversified healthcare company. (Date of Birth – 15 November 1948).
Non-executive Director. Former head of Shield Diagnostics (now Axis-Shield plc), where he spearheaded the initial stages of development of a new diagnostic for heart problems. Mr. Hall has also held senior positions at US healthcare giant Abbott. He was appointed to the Board as executive Chairman in September 1998, becoming non-executive Chairman in February 2001 and stepping down as Chairman on 12 August 2008. (Date of Birth – 18 August 1942).
Chief Executive Officer. Formerly COO at Osmetech for more than 2 years and was instrumental in the restructuring of the organisation as a medical devices company. He was appointed Chief Executive Officer in December 2000. Prior to joining Osmetech, Mr. White was a senior consultant in Arthur D. Little Ltd's corporate finance practice. As Chief Executive Officer and an Executive Director, Mr White has overall responsibility for the strategic development of the Group.(Date of Birth – 30 November 1970)
Non-Executive Director from September 2002. Appointed to the Board in February 1998 as Director of Development and was appointed Chief Technology Officer in October 1999. Founder and former Chief Executive of Neopath, a diagnostic imaging company, and Advanced Technology Labs, a medical diagnostic ultrasound company later acquired by Squibb Corporation. Mr Kuenster is also Chairman of UMD Technology Inc. (Date of Birth – 9 November 1933)
Chief Financial Officer. Previously Group Finance Director of London-listed Bluebird Toys, until its take-over by Mattel Inc. Mr. Sandilands qualified as a Chartered Accountant with Price Waterhouse. He was appointed to the Board in July 1999. As Chief Financial Officer and an Executive Director, Mr Sandilands is responsible for the Group's financial reporting, treasury and financial management functions. (Date of Birth – 11 April 1961)
|
